Vka Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 5 Days
- Last Filing with ROC 31 Mar 2024
About Vka Pharma
Vka Pharma Private Limited (VPPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 February 2014 and has a history of 11 years. Its registered office is in Kolkata, West Bengal, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Amit Agarwal and Krishna Agarwal serve as directors at the Company.
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74110WB2014PTC200326
- Company No.
200326
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Feb 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Vka Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Agarwal  | Director | 18-Feb-2014 | Current |
| Krishna Agarwal | Director | 22-Aug-2016 | Current |
Financial Performance of Vka Pharma.
Vka Pharma Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Vka Pharma?
In 2017, Vka Pharma had a promoter holding of 50.00% and a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shivohum Infrastructure And Projects Private LimitedKrishna Agarwal is a mutual person
Janki Mirra Brewery Private LimitedAmit Agarwal is a mutual person
- Shivohum Hospitality Private Limited
Amit Agarwal is a mutual person
- Shivohum Greentech Private Limited
Amit Agarwal and Krishna Agarwal are mutual person
- Bmv Construction Private Limited
Amit Agarwal is a mutual person
- Janki Mirra Resorts Private Limited
Amit Agarwal is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vka Pharma?
Unlock and access historical data on people associated with Vka Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vka Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vka Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
